Group II metabotropic glutamate receptors as targets for novel antipsychotic drugs
Schizophrenia is a chronic psychiatric disorder which substantially impairs patients' quality of life. Despite the extensive research in this field, the pathophysiology and aetiology of schizophrenia remain unknown. Different neurotransmitter systems and functional networks have been found to b...
Saved in:
Main Authors: | Carolina eMuguruza (Author), Javier eMeana (Author), Luis F Callado (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2016-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Antipsychotic profiles of TASP0443294, a novel and orally active positive allosteric modulator of metabotropic glutamate 2 receptor
by: Hirohiko Hikichi, et al.
Published: (2015) -
Metabotropic Glutamate Receptors and Neurological/Psychiatric Disorders
Published: (2019) -
Group I metabotropic glutamate receptor-mediated gene transcription and implications for synaptic plasticity and diseases
by: Hansen eWang, et al.
Published: (2012) -
Group 1 metabotropic glutamate receptor function and its regulation of learning and memory in the aging brain
by: Caroline eMénard, et al.
Published: (2012) -
Capsaicin-Induced Glutamate Release Is Implicated in Nociceptive Processing Through Activation of Ionotropic Glutamate Receptors and Group I Metabotropic Glutamate Receptor in Primary Afferent Fibers
by: You-Hong Jin, et al.
Published: (2009)